Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Surrozen
Surrozen
Surrozen stops IBD program due to dose concerns and competition
Fierce Biotech
Thu, 01/18/24 - 11:18 am
Surrozen
inflammatory bowel disease
SZN-1326
clinical trials
Boehringer and Surrozen Seek Retinal Therapies Along the Wnt Pathway
BioSpace
Fri, 10/7/22 - 10:39 am
Boehringer Ingelheim
Surrozen
Wnt pathway
retinal diseases
R&D
Regenerative medicine biotech Surrozen aims for the Nasdaq in $212M SPAC deal
Fierce Biotech
Fri, 04/16/21 - 10:05 am
Surrozen
regenerative medicine
SPAC